Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Applied Genomic Technology Capital Funds

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 3
Rounds per year 0.14
Lead investments 1
Exits 2
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Medical
  • Biotechnology
  • Therapeutics
  • Pharmaceutical
  • Health Care
Summary

Applied Genomic Technology Capital Funds appeared to be the VC, which was created in 2000. The leading representative office of defined VC is situated in the Cambridge. The fund was located in North America if to be more exact in United States.

Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Innovation Management, Medical. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Morphotek.

The increased amount of exits for fund were in 2007. The important activity for fund was in 2001. Deals in the range of 5 - 10 millions dollars are the general things for fund. The typical startup value when the investment from Applied Genomic Technology Capital Funds is 10-50 millions dollars. The fund is constantly included in less than 2 deals per year.

The standard case for the fund is to invest in rounds with 4-5 partakers. The meaningful sponsors for the fund in investment in the same round are Venrock, Turnbridge Capital, Prospect Venture Partners. In the next rounds fund is usually obtained by Rock Maple Ventures, Morgenthaler Ventures, Forward Ventures.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Applied Genomic Technology Capital Funds:
Typical Co-investors
Applied Genomic Technology Capital Funds is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Applied Genomic Technology Capital Funds:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Avansis Ventures Clifton Forge, United States, Virginia
Bragiel Brothers California, San Francisco, United States
Catapult Trust -
Columbia Threadneedle Investments England, London, United Kingdom
Egypt Ventures Colombia, El Cairo, Valle del Cauca
Gaolu Ventures -
H2020 Chile, Providencia, Region Metropolitana
Hanying Jijin China, Guangdong, Shenzhen
Ready Ventures Central, Central Region, Singapore
Zhejiang Chengzhang Wenhua Guquan Touzi China, Hangzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

AVEO Oncology

Biotechnology
Health Care
Medical
Pharmaceutical
Therapeutics
$5M05 May 2005 Cambridge, Massachusetts, United States

Morphotek

Biotechnology
Innovation Management
Medical
$10M13 Aug 2001 Exton, Pennsylvania, United States

Hypnion

Biotechnology
Health Diagnostics
Medical
Therapeutics
$10M06 Oct 2000 Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Applied Genomic Technology Capital Funds?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 8M
Rounds per year 0.14
Peak activity year 2005
Lead investments 1
Exits 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

AVEO Oncology

Biotechnology
Health Care
Medical
Pharmaceutical
Therapeutics
$5M05 May 2005 Cambridge, Massachusetts, United States

Morphotek

Biotechnology
Innovation Management
Medical
$10M13 Aug 2001 Exton, Pennsylvania, United States

Hypnion

Biotechnology
Health Diagnostics
Medical
Therapeutics
$10M06 Oct 2000 Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: